Cold Case Solved

Showing 3559 articles
Business

Clearway Energy's Valuation Puzzle: DCF Model Signals Deep Discount, But P/E Ratio Tells a Different Story

Shares of renewable energy producer Clearway Energy have delivered strong long-term gains, but recent trading has been mixed. A deep dive into its valuation reveals a stark contradiction: a discounted cash flow model suggests the stock is significantly undervalued, while its price-to-earnings multiple appears rich compared to a proprietary fair ratio. Investors are left weighing which metric paints the truer picture.

Business

IHS Towers: A Deep-Value Play Emerges as Currency Headwinds Shift

IHS Holding Limited, a leading telecom tower operator in emerging markets, is seeing a dramatic reversal in its investment narrative. Long pressured by currency devaluations, the company now stands to benefit from FX tailwinds, operational improvements, and surging data demand, presenting a compelling bull case at a valuation far below peers.

Business

C4 Therapeutics: Can Its Protein-Degrading Tech Ignite a Biotech Rally?

Amid a challenging market for biotech, C4 Therapeutics (NASDAQ: CCCC) is drawing investor attention with its targeted protein degradation platform. Backed by industry giants and focused on niche cancers, the clinical-stage company presents a high-risk, high-reward proposition. We examine the bull case and the road ahead.

Business

Rollins, Inc.: The Quiet Compounders in Pest Control

Amid market volatility, Rollins, Inc. (NYSE: ROL) represents a compelling case for stability. This analysis explores the pest control leader's resilient business model, built on recurring revenue and disciplined growth, which has delivered exceptional long-term returns for shareholders.